- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4155 - 1,2-Diazoles not condensed and containing further heterocyclic rings
Patent holdings for IPC class A61K 31/4155
Total number of patents in this class: 2642
10-year publication summary
|
139
|
183
|
181
|
179
|
199
|
196
|
162
|
206
|
195
|
138
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Incyte Corporation | 1066 |
42 |
| Novartis AG | 10224 |
36 |
| Takeda Pharmaceutical Company Limited | 2713 |
34 |
| Hua Medicine (Shanghai) Ltd. | 53 |
33 |
| F. Hoffmann-La Roche AG | 7816 |
31 |
| Pfizer Inc. | 3400 |
24 |
| Boehringer Ingelheim International GmbH | 4487 |
23 |
| Bristol-myers Squibb Company | 4747 |
22 |
| Hoffmann-La Roche Inc. | 3804 |
22 |
| AstraZeneca AB | 2820 |
22 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3314 |
22 |
| The Regents of the University of California | 20790 |
21 |
| Epizyme, Inc. | 360 |
21 |
| Daiichi Sankyo Company, Limited | 1890 |
20 |
| Vanderbilt University | 2025 |
20 |
| Yeda Research and Development Co. Ltd. | 1381 |
20 |
| LG Chem, Ltd. | 17937 |
19 |
| Merck Sharp & Dohme LLC | 3737 |
19 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3002 |
18 |
| ChemoCentryx, Inc. | 361 |
17 |
| Other owners | 2156 |